Ipecacuanha

Jump to: navigation, search
Ipecacuanha
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rabin Bista, M.B.B.S. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Overview

Ipecacuanha is a OTC emetic that is FDA approved for the treatment of of Poisoning, acute by inducing vomiting. Common adverse reactions include Diarrhea, Stomach cramps, Myalgia and Lethargy.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indications

Dosage

(Adults / Children 2-18 years)
  • Allow 3 or 4 pellets to dissolve in the mouth 3 times a day until symptoms are relieved or as directed by a health professional.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Ipecacuanha in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Ipecacuanha in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Indications

  • Poisoning, acute[1]

Dosage

(Adults / Children 2-18 years)
  • Allow 3 or 4 pellets to dissolve in the mouth 3 times a day until symptoms are relieved or as directed by a health professional.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Ipecacuanha in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Ipecacuanha in pediatric patients.

Contraindications

There is limited information regarding Ipecacuanha Contraindications in the drug label.

Warnings

There is limited information regarding Ipecacuanha Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

Postmarketing Experience

There is limited information regarding Ipecacuanha Postmarketing Experience in the drug label.

Drug Interactions

There is limited information regarding Ipecacuanha Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • If pregnant or breast-feeding, ask a health professional before use


Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Ipecacuanha in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Ipecacuanha during labor and delivery.

Nursing Mothers

  • If pregnant or breast-feeding, ask a health professional before use

Pediatric Use

There is no FDA guidance on the use of Ipecacuanha with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Ipecacuanha with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Ipecacuanha with respect to specific gender populations.

Race

There is no FDA guidance on the use of Ipecacuanha with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Ipecacuanha in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Ipecacuanha in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Ipecacuanha in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Ipecacuanha in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Oral

Monitoring

There is limited information regarding Monitoring of Ipecacuanha in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Ipecacuanha in the drug label.

Overdosage

There is limited information regarding Overdose of Ipecacuanha in the drug label.

Pharmacology

There is limited information regarding Ipecacuanha Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Ipecacuanha Mechanism of Action in the drug label.

Structure

ACTIVE INGREDIENT HPUS

IPECACUANHA 3X

(Ipecac)

INACTIVE INGREDIENTS

Lactose, sucrose.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Ipecacuanha in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Ipecacuanha in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Ipecacuanha in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Ipecacuanha in the drug label.

How Supplied

There is limited information regarding Ipecacuanha How Supplied in the drug label.

Storage

  • Store at room temperature.

Images

Drug Images

Package and Label Display Panel

LABEL

This image is provided by the National Library of Medicine.

Ingredients and Appearance

This image is provided by the National Library of Medicine.

Patient Counseling Information

  • QUESTIONS?
1-800-404-4666

Precautions with Alcohol

  • Alcohol-Ipecacuanha interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

  • IPECACUANHA®[4]

Look-Alike Drug Names

There is limited information regarding Ipecacuanha Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. 1.0 1.1 Krenzelok EP, Dean BS (1985). "Syrup of ipecac in children less than one year of age.". J Toxicol Clin Toxicol. 23 (2-3): 171–6. PMID 2865374. 
  2. Litovitz T (1988). "In defense of retaining ipecac syrup as an over-the-counter drug.". Pediatrics. 82 (3 Pt 2): 514–6. PMID 2900493. 
  3. 3.0 3.1 Czajka PA, Russell SL (1985). "Nonemetic effects of ipecac syrup.". Pediatrics. 75 (6): 1101–4. PMID 2860632. 
  4. "Ipecacuanha pellet". 

Linked-in.jpg